Do any topical acne therapies alter the structural and/or functional integrity of the epidermal
barrier? J Clin Aesthet Dermatol 6:18–24
Thotakura N, Kumar P, Wadhwa S, Raza K, Katare P (2017) Dermatokinetics as an important tool
to assess the bioavailability of drugs by topical nanocarriers. Curr Drug Metab 18:404–411.
https://doi.org/10.2174/1389200218666170306104042
Turner NG, Kalia YN, Guy RH (1997) The effect of current on skin barrier function in vivo:
recovery kinetics post-iontophoresis. Pharm Res 14(9):1252–1257. https://doi.org/10.1023/
A:1012175428181
Üner M, Yener G (2007) Importance of solid lipid nanoparticles (SLN) in various administration
routes and future perspective. Int J Nanomedicine 2:289–300
Vaghasiya H, Kumar A, Sawant K (2013) Development of solid lipid nanoparticles based con-
trolled release system for topical delivery of terbinafine hydrochloride. Eur J Pharm Sci 49:311–
322. https://doi.org/10.1016/j.ejps.2013.03.013
Wang Y, Allen LV, Li LC, Tu Y-H (1993) Iontophoresis of hydrocortisone across hairless
mouse skin: investigation of skin alteration. J Pharm Sci 82:1140–1144. https://doi.org/10.
1002/jps.2600821115
Wasserman D, Guzman-Sanchez DA, Scott K, Mcmichael A (2007) Alopecia areata. Int J Dermatol
46:121–131. https://doi.org/10.1111/j.1365-4632.2007.03193.x
Wiechers JW (1989) The barrier function of the skin in relation to percutaneous absorption of drugs.
Pharm Weekbl Sci Ed 11:185–198. https://doi.org/10.1007/BF01959410
Yadav H, Kumar P, Sharma V, Sharma G, Raza K, Katare OP (2016) Enhanced efficacy and a better
pharmacokinetic profile of tamoxifen employing polymeric micelles. RSC Adv 6:53351–53357.
https://doi.org/10.1039/c6ra10874a
Zamarioli CM, Martins RM, Carvalho EC, Freitas LAP (2015) Nanoparticles containing
curcuminoids (Curcuma longa): development of topical delivery formulation. Rev Bras Farm
25:53–60. https://doi.org/10.1016/j.bjp.2014.11.010
Zhang YT, Shen LN, Wu ZH, Zhao JH, Feng NP (2014) Comparison of ethosomes and liposomes
for skin delivery of psoralen for psoriasis therapy. Int J Pharm 471:449–452. https://doi.org/10.
1016/j.ijpharm.2014.06.001
230
R. K. Paul et al.